Jw Life Science Corp (234080) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.023x

Based on the latest financial reports, Jw Life Science Corp (234080) has a cash flow conversion efficiency ratio of 0.023x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.08 Billion ≈ $3.44 Million USD) by net assets (₩220.58 Billion ≈ $149.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jw Life Science Corp defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Jw Life Science Corp - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Jw Life Science Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jw Life Science Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Life Science Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Value Valves Co Ltd TWO:4580	0.051x
Abra Information Technologies TA:ABRA	0.008x
IRM ENERGY LTD NSE:IRMENERGY	0.085x
Hansae Yes24 KO:016450	0.105x
Mangata Holding S.A. WAR:MGT	-0.002x
BICO Group AB ST:BICO	-0.017x
Avita Medical Inc AU:AVH	0.411x
Lake Superior Acquisition Corp. Class A Ordinary Shares NASDAQ:LKSP	-0.003x

Annual Cash Flow Conversion Efficiency for Jw Life Science Corp (2015–2025)

The table below shows the annual cash flow conversion efficiency of Jw Life Science Corp from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Jw Life Science Corp worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩220.58 Billion ≈ $149.48 Million	₩40.54 Billion ≈ $27.47 Million	0.184x	-27.33%
2024-12-31	₩200.44 Billion ≈ $135.84 Million	₩50.69 Billion ≈ $34.35 Million	0.253x	+7.28%
2023-12-31	₩159.39 Billion ≈ $108.02 Million	₩37.57 Billion ≈ $25.46 Million	0.236x	+134.14%
2022-12-31	₩140.33 Billion ≈ $95.10 Million	₩14.13 Billion ≈ $9.57 Million	0.101x	-56.11%
2021-12-31	₩131.49 Billion ≈ $89.11 Million	₩30.17 Billion ≈ $20.44 Million	0.229x	-35.20%
2020-12-31	₩132.06 Billion ≈ $89.50 Million	₩46.75 Billion ≈ $31.68 Million	0.354x	+78.82%
2019-12-31	₩122.62 Billion ≈ $83.09 Million	₩24.28 Billion ≈ $16.45 Million	0.198x	-40.13%
2018-12-31	₩109.26 Billion ≈ $74.04 Million	₩36.13 Billion ≈ $24.48 Million	0.331x	+53.12%
2017-12-31	₩102.10 Billion ≈ $69.19 Million	₩22.05 Billion ≈ $14.94 Million	0.216x	+21.27%
2016-12-31	₩90.30 Billion ≈ $61.20 Million	₩16.08 Billion ≈ $10.90 Million	0.178x	-43.04%
2015-12-31	₩82.83 Billion ≈ $56.13 Million	₩25.90 Billion ≈ $17.55 Million	0.313x	--

About Jw Life Science Corp

KO:234080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$120.47 Million

₩177.76 Billion KRW

Market Cap Rank

#18580 Global

#859 in Korea

Share Price

₩11480.00

Change (1 day)

-0.43%

52-Week Range

₩10730.00 - ₩15500.00

All Time High

₩26817.34